NNNN
NASDAQ
$9.52
Anbio Biotechnology - Class A (NNNN)
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. The company is headquartered in Frankfurt am Main, Germany.
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Market Cap
$398M
PEG Ratio
0.39
Profit Margin
74.1%
P/E Ratio
62.20
Price Chart
Valuation
Market Cap$398M
P/E62.20
PEG0.39
P/S46.29
P/B13.62
Profitability
Total Revenue (TTM)$8.65M
Gross Profit (TTM)$7.54M
EBITDA$6.40M
Profit Margin74.1%
Operating Margin66.7%
EPS$0.15
Financial Health
Free Cash Flow Yield-1.69%
Growth & Risk
Beta (5Y)0.28
Sharpe Ratio-0.38